Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: A population-based case-control study

American Journal of Gastroenterology

Volumn 105, Issue 8, 2010, Pages 1843-1850

  Long, Millie D ^a,b   Martin, Christopher F ^a,b   Galanko, Joseph A ^a   Sandler, Robert S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AFRICAN AMERICAN; AGE; ARTICLE; CAUCASIAN; CLINICAL EVALUATION; COLON ADENOCARCINOMA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; LARGE INTESTINE CANCER; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MARRIAGE; MENOPAUSE; ORAL CONTRACEPTION; PARITY; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PRIORITY JOURNAL; RACE; RECTUM CARCINOMA; RED MEAT; RISK; RISK FACTOR; RISK REDUCTION; SIGMOID CARCINOMA; SMOKING; TREATMENT DURATION;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONTRACEPTIVES, ORAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; LOGISTIC MODELS; MIDDLE AGED; NORTH CAROLINA; QUESTIONNAIRES; REGISTRIES; RISK FACTORS;

EID: 77955425438     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2010.123     Document Type: Article

References (51)

1. http://seer.cancer.gov/faststats/selections.php # Output. Accessed November2009.
2. Lin J, Zhang SM, Cook NR et al. Oral contraceptives, reproductive factors,and risk of colorectal cancer among women in a prospective cohort study.Am J Epidemiol 2007; 165: 794-801.
3. Fernandez E, La Vecchia C, Balducci A et al. Oral contraceptives and colorectalcancer risk: a meta-analysis. Br J Cancer 2001; 84: 722-727
4. Rossouw JE, Anderson GL, Prentice RL et al. Risks and benefits of estrogenplus progestin in healthy postmenopausal women: principal resultsFrom the Women's Health Initiative randomized controlled trial. JAMA2002; 288: 321-333
5. Gervaz P, Bouzourene H, Cerottini JP et al. Dukes B colorectal cancer:distinct genetic categories and clinical outcome based on proximal or distaltumor location. Dis Colon Rectum 2001; 44: 364-72; discussion 72-73
6. Li M, Li JY, Zhao AL et al. Colorectal cancer or colon and rectal cancer?Clinicopathological comparison between colonic and rectal carcinomas.Oncology 2008; 73: 52-57
7. Slattery ML, Curtin K, WolffRK et al. A comparison of colon and rectalsomatic DNA alterations. Dis Colon Rectum 2009; 52: 1304-1311
8. Talamini R, Franceschi S, Dal Maso L et al. The influence of reproductiveand hormonal factors on the risk of colon and rectal cancer in women. EurJ Cancer 1998; 34: 1070-1076
9. Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapyand the risk of colorectal cancer: a review and meta-analysis. Am J Med1999; 106: 574-582
10. Aldrich TE, Vann D, Moorman PG et al. Rapid reporting of cancer incidencein a population-based study of breast cancer: one constructive use ofa central cancer registry. Breast Cancer Res Treat 1995; 35: 61-64
11. Weinberg CR, Wacholder S. The design and analysis of case-control studieswith biased sampling. Biometrics 1990; 46: 963-975
12. Blair SN, Haskell WL, Ho P et al. Assessment of habitual physical activityby a seven-day recall in a community survey and controlled experiments.Am J Epidemiol 1985; 122: 794-804.
13. Richardson MT, Ainsworth BE, Jacobs DR et al. Validation of theStanford 7-day recall to assess habitual physical activity. Ann Epidemiol2001; 11: 145-153
14. Th ompson FE, Subar AF, Brown CC et al. Cognitive research enhancesaccuracy of food frequency questionnaire reports: results of an experimentalvalidation study. J Am Diet Assoc 2002; 102: 212-225
15. Subar AF, Th ompson FE, Kipnis V et al. Comparative validation of theBlock, Willett, and National Cancer Institute food frequency questionnaires: The Eating at America's Table Study. Am J Epidemiol 2001; 154: 1089-1099
16. Weinberg CR, Sandler DP. Randomized recruitment in case-control studies.Am J Epidemiol 1991; 134: 421-432
17. Purdue MP, Mink PJ, Hartge P et al. Hormone replacement therapy,reproductive history, and colorectal adenomas: data from the Prostate, Lung,Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).Cancer Causes Control 2005; 16: 965-973
18. Potter JD, Bostick RM, Grandits GA et al. Hormone replacement therapyis associated with lower risk of adenomatous polyps of the large bowel: theMinnesota Cancer Prevention Research Unit Case-Control Study. CancerEpidemiol Biomarkers Prev 1996; 5: 779-784
19. Peipins LA, Newman B, Sandler RS. Reproductive history, use of exogenoushormones, and risk of colorectal adenomas. Cancer Epidemiol BiomarkersPrev 1997; 6: 671-675
20. Prentice RL, Pettinger M, Beresford SA et al. Colorectal cancer in relationto postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study. Cancer EpidemiolBiomarkers Prev 2009; 18: 1531-1537
21. Paganini-Hill A. Estrogen replacement therapy and colorectal cancer risk inelderly women. Dis Colon Rectum 1999; 42: 1300-1305
22. Calle EE, Miracle-McMahill HL, Th un MJ et al. Estrogen replacementtherapy and risk of fatal colon cancer in a prospective cohort of postmenopausalwomen. J Natl Cancer Inst 1995; 87: 517-523
23. Persson I, Yuen J, Bergkvist L et al. Cancer incidence and mortality inwomen receiving estrogen and estrogen-progestin replacement therapy-long-term follow-up of a Swedish cohort. Int J Cancer 1996; 67: 327-332
24. Furner SE, Davis FG, Nelson RL et al. A case-control study of large bowelcancer and hormone exposure in women. Cancer Res 1989; 49: 4936-4940
25. Risch HA, Howe GR. Menopausal hormone use and colorectal cancer inSaskatchewan: a record linkage cohort study. Cancer Epidemiol BiomarkersPrev 1995; 4: 21-28
26. Grodstein F, Martinez ME, Platz EA et al. Postmenopausal hormone use andrisk for colorectal cancer and adenoma. Ann Intern Med 1998; 128: 705-712
27. Fernandez E, La Vecchia C, Braga C et al. Hormone replacement therapyand risk of colon and rectal cancer. Cancer Epidemiol Biomarkers Prev1998; 7: 329-333
28. Troisi R, Schairer C, Chow WH et al. A prospective study of menopausalhormones and risk of colorectal cancer (United States). Cancer CausesControl 1997; 8: 130-138
29. Newcomb PA, Storer BE. Postmenopausal hormone use and risk of largebowelcancer. J Natl Cancer Inst 1995; 87: 1067-1071
30. Potter JD, McMichael AJ. Large bowel cancer in women in relation toreproductive and hormonal factors: a case-control study. J Natl Cancer Inst1983; 71: 703-709
31. Nichols HB, Trentham-Dietz A, Hampton JM et al. Oral contraceptive use,reproductive factors, and colorectal cancer risk: findings from Wisconsin.Cancer Epidemiol Biomarkers Prev 2005; 14: 1212-1218
32. Bosetti C, Bravi F, Negri E et al. Oral contraceptives and colorectalcancer risk: a systematic review and meta-analysis. Hum Reprod Update2009; 15: 489-498
33. Marchbanks PA, McDonald JA, Wilson HG et al. Oral contraceptives andthe risk of breast cancer. N Engl J Med 2002; 346: 2025-2032
34. McMichael AJ, Potter JD. Host factors in carcinogenesis: certain bile-acidmetabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 1985; 75: 185-191
35. Lointier P, Wildrick DM, Boman BM. The effects of steroid hormones on ahuman colon cancer cell line in vitro. Anticancer Res 1992; 12: 1327-1330
36. Campagnoli C, Biglia N, Cantamessa C et al. Insulin-like growth factor I(IGF-I) serum level modifications during transdermal estradiol treatmentin postmenopausal women: a possible bimodal effect depending on basalIGF-I values. Gynecol Endocrinol 1998; 12: 259-266
37. Newcomb PA, Zheng Y, Chia VM et al. Estrogen plus progestin use, microsatelliteinstability, and the risk of colorectal cancer in women. Cancer Res2007; 67: 7534-7539
38. Slattery ML, Potter JD, Curtin K et al. Estrogens reduce and with drawal ofestrogens increase risk of microsatellite instability-positive colon cancer.Cancer Res 2001; 61: 126-130
39. Moore LL, Bradlee ML, Singer MR et al. BMI and waist circumference aspredictors of lifetime colon cancer risk in Framingham Study adults. Int JObes Relat Metab Disord 2004; 28: 559-567
40. Pischon T, Lahmann PH, Boeing H et al. Body size and risk of colon andrectal cancer in the European Prospective Investigation Into Cancer andNutrition (EPIC). J Natl Cancer Inst 2006; 98: 920-931 (Pubitemid 44018922)
41. Chao A, Th un MJ, Connell CJ et al. Meat consumption and risk of colorectalcancer. JAMA 2005; 293: 172-182
42. Rosenberg L, Louik C, Shapiro S. Nonsteroidal antiinflammatory drug useand reduced risk of large bowel carcinoma. Cancer 1998; 82: 2326-2333
43. Lokkegaard EL, Johnsen SP, Heitmann BL et al. The validity of self-reporteduse of hormone replacement therapy among Danish nurses. Acta ObstetGynecol Scand 2004; 83: 476-481
44. Jain MG, Rohan TE, Howe GR. Agreement of self-reported use of menopausalhormone replacement therapy with physician reports. Epidemiology1999; 10: 260-263
45. Goodman MT, Nomura AM, Wilkens LR et al. Agreement between interviewinformation and physician records on history of menopausal estrogenuse. Am J Epidemiol 1990; 131: 815-825
46. Matthews KA, Kuller LH, Wing RR et al. Prior to use of estrogenreplacement therapy, are users healthier than nonusers? Am J Epidemiol1996; 143: 971-978
47. Hing E, Brett KM. Changes in U.S. prescribing patterns of menopausalhormone therapy, 2001-2003. Obstet Gynecol 2006; 108: 33-40.
48. Mishra G, Kok H, Ecob R et al. Cessation of hormone replacement therapyaft er reports of adverse findings from randomized controlled trials: evidencefrom a British Birth Cohort. Am J Public Health 2006; 96: 1219-1225
49. Watson J, Wise L, Green J. Prescribing of hormone therapy for menopause,tibolone, and bisphosphonates in women in the UK between 1991 and2005. Eur J Clin Pharmacol 2007; 63: 843-849
50. French LM, Smith MA, Holtrop JS et al. Hormone therapy aft er the Women'sHealth Initiative: a qualitative study. BMC Fam Pract 2006; 7: 61.
51. Isaacs AJ, Drew SV, McPherson K. UK women doctors'use of hormonereplacement therapy: 10-year follow up. Climacteric 2005; 8: 154-161